August 2020 Publications
- Tuberculosis vaccine development: from classic to clinical candidates. Li J, Zhao A, Tang J, Wang G, Shi Y, Zhan L, Qin C. Eur J Clin Microbiol Infect Dis. 2020 Aug. doi: 10.1007/s10096-020-03843-6. Epub 2020 Feb 15.
- Mycobacterium tuberculosis-specific plasmablast levels are differentially modulated in tuberculosis infection and disease. Gindeh A, Owolabi O, Donkor S, Sutherland JS. Tuberculosis (Edinb). 2020 Aug 1. doi: 10.1016/j.tube.2020.101978. Online ahead of print.
- Nutritional status positively impacts humoral immunity against its Mycobacterium tuberculosis, disease progression, and vaccine development. Niki M, Yoshiyama T, Nagai H, Miyamoto Y, Niki M, Oinuma KI, Tsubouchi T, Kaneko Y, Matsumoto S, Sasaki Y, Hoshino Y. PLoS One. 2020 Aug 6. doi: 10.1371/journal.pone.0237062. eCollection 2020.
- The effect of Bacillus Calmette-Guérin (BCG) vaccination in preventing sever infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic. Yitbarek K, Abraham G, Girma T, Tilahun T, Woldie M. Vaccine. 2020 Aug 10. doi: 10.1016/j.vaccine.2020.08.018. Online ahead of print. Review.
- Impact of routine infant BCG vaccination in young generation on prevention of local COVID-19 spread in Japan. Kinoshita M, Tanaka M. J Infect. 2020 Aug 11. doi: 10.1016/j.jinf.2020.08.013. Online ahead of print.
- Development of a Counterselectable Transposon To Create Markerless Knockouts from an 18,432-Clone Ordered Mycobacterium bovis Bacillus Calmette-Guérin Mutant Resource. Borgers K, Vandewalle K, Van Hecke A, Michielsen G, Plets E, van Schie L, Vanmarcke S, Schindfessel L, Festjens N, Callewaert N. mSystems. 2020 Aug 11. doi: 10.1128/mSystems.00180-20.
- Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium. Tanaka K, Enomoto N, Uehara M, Furuhashi K, Sakurai S, Yasui H, Karayama M, Hozumi H, Suzuki Y, Fujisawa T, Inui N, Nakamura Y, Nagata T, Suda T. Microbiol Immunol. 2020 Aug 12. doi: 10.1111/1348-0421.12836. Online ahead of print.
- Lymph nodes-The neglected battlefield in tuberculosis. Ganchua SKC, White AG, Klein EC, Flynn JL. PLoS Pathog. 2020 Aug 13. doi: 10.1371/journal.ppat.1008632. eCollection 2020 Aug. Review.
- The Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S, Perovic VR, Sencanski M, Paessler S, Veljkovic V. J Proteome Res. 2020 Aug 14. doi: 10.1021/acs.jproteome.0c00410. Online ahead of print.
- Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls. Suliman S, Gela A, Mendelsohn SC, Iwany SK, Tamara KL, Mabwe S, Bilek N, Darboe F, Fisher M, Corbett AJ, Kjer-Nielsen L, Eckle SBG, Huang CC, Zhang Z, Lewinsohn DM, McCluskey J, Rossjohn J, Hatherill M, León SR, Calderon RI, Lecca L, Murray M, Scriba TJ, Van Rhijn I, Moody DB. J Infect Dis. 2020 Aug 17. doi: 10.1093/infdis/jiaa173.
- Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health. Fries CN, Curvino EJ, Chen JL, Permar SR, Fouda GG, Collier JH. Nat Nanotechnol. 2020 Aug 17. doi: 10.1038/s41565-020-0739-9. Online ahead of print.
- First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse events. Narvskaya O, Starkova D, Levi D, Alexandrova N, Molchanov V, Chernyaeva E, Vyazovaya A, Mushkin A, Zhuravlev V, Solovieva N, Vishnevskiy B, Mokrousov I. BMC Genomics. 2020 Aug 18. doi: 10.1186/s12864-020-06973-5.
- The impact of human single nucleotide polymorphisms on Bacillus Calmette-Guérin responses. Messina NL, Netea MG, Curtis N. Vaccine. 2020 Aug 18. doi: 10.1016/j.vaccine.2020.07.032. Online ahead of print.
- MAIT cell-directed therapy of Mycobacterium tuberculosis infection. Sakai S, Kauffman KD, Oh S, Nelson CE, Barry CE 3rd, Barber DL. Mucosal Immunol. 2020 Aug 18. doi: 10.1038/s41385-020-0332-4. Online ahead of print.
- Antituberculosis BCG vaccination: more reasons for varying innate and adaptive immune responses. Prentice S, Dockrell HM. J Clin Invest. 2020 Aug 19. doi: 10.1172/JCI141317. Online ahead of print.
- Integrating fish models in tuberculosis vaccine development. Saralahti AK, Uusi-Mäkelä MIE, Niskanen MT, Rämet M. Dis Model Mech. 2020 Aug 23. doi: 10.1242/dmm.045716.
- BCG vaccination in infancy does not protect against COVID-19. Evidence from a natural experiment in Sweden. de Chaisemartin C, de Chaisemartin L. Clin Infect Dis. 2020 Aug 23. doi: 10.1093/cid/ciaa1223. Online ahead of print.
- A new step toward tuberculosis vaccine? Tersigni C, Galli L.EBioMedicine. 2020 Aug 25;59:102965. doi: 10.1016/j.ebiom.2020.102965. Online ahead of print.
- Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes. Sathkumara HD, Muruganandah V, Cooper MM, Field MA, Alim MA, Brosch R, Ketheesan N, Govan B, Rush CM, Henning L, Kupz A. Proc Natl Acad Sci U S A. 2020 Aug 25. doi: 10.1073/pnas.2003235117. Epub 2020 Aug 10.
- Is There a Rationale for Using Bacillus Calmette-Guerin Vaccine in Coronavirus Infection? Maheshwari N, Jain A. Viral Immunol. 2020 Aug 26. doi: 10.1089/vim.2020.0079. Online ahead of print.
- Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2. Glisic S, Perovic VR, Sencanski M, Paessler S, Veljkovic V. J Proteome Res. 2020 Aug 28. doi: 10.1021/acs.jproteome.0c00410. Online ahead of print.
- Correlation between immunity from BCG and the morbidity and mortality of COVID-19. Wickramasinghe D, Wickramasinghe N, Kamburugamuwa SA, Arambepola C, Samarasekera DN. Trop Dis Travel Med Vaccines. 2020 Aug 28. doi: 10.1186/s40794-020-00117-z. eCollection 2020
- Mycobacterium tuberculosis infection is associated with increased B cell responses to unrelated pathogens. Kimuda SG, Andia-Biraro I, Sebina I, Egesa M, Nalwoga A, Smith SG, Bagaya BS, Levin J, Elliott AM, Raynes JG, Cose S. Sci Rep. 2020 Aug 31. doi: 10.1038/s41598-020-71044-4.